Inventor · disambiguated record
Barbara A. Belli
Also filed as: BELLI BARBARA · BELLI BARBARA A
11 granted patents·4 pending applications·660 citations·filing 1996–2013
94Inventor score
Top patents by PatentIndex Score
15 records- 0198US5843723AAlphavirus vector constructsCHIRON CORP·Filed 1996·Granted Dec 1, 1998·327 cites·47 claims
- 0297US7977091B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Jul 12, 2011·38 cites·4 claims
- 0395US8357690B2Methods of treatment using combination therapyAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 22, 2013·25 cites·44 claims
- 0494US7811812B2Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Oct 12, 2010·43 cites·16 claims
- 0592US7744900B2Enhancement of the immune response for vaccine and gene therapy applicationsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted Jun 29, 2010·20 cites·15 claims
- 0690US6391632B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted May 21, 2002·63 cites·28 claims
- 0788US7572628B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Aug 11, 2009·9 cites·34 claims
- 0886US6451592B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1997·Granted Sep 17, 2002·50 cites·26 claims
- 0985US8836218B2Methods of treatment using combination therapyAMBIT BIOSCIENCES CORP·Filed 2013·Granted Sep 16, 2014·3 cites·27 claims
- 1079US6465634B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted Oct 15, 2002·45 cites·25 claims
- 1173US6458560B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted Oct 1, 2002·37 cites·24 claims
- 1261US2004029278A1Eukaryotic layered vector initiation systemsCHIRON CORP·Filed 2002·Application pending·0 cites
- 1360US2010330121A1Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesisNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 1444US2003170871A1Alphavirus-based vectors for persistent infectionCHIRON CORP·Filed 2001·Application pending·0 cites
- 1535US2012053176A1Adenosine a3 receptor modulating compounds and methods of use thereofARMSTRONG ROBERT C·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →